Published in
Taylor and Francis Group, OncoImmunology, p. e1456603
DOI: 10.1080/2162402x.2018.1456603
Links
Tools
Heterologous vaccination targeting prostatic acid phosphatase (PAP) using DNA andListeriavaccines elicits superior anti-tumor immunity dependent on CD4+ T cells elicited by DNA priming
Journal article published in 2018 by
Laura E. Johnson,
Dirk Brockstedt,
Meredith Leong,
Peter Lauer,
Erin Theisen,
John-Demian Sauer,
Douglas G. McNeel 
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 